New Key Statistics Module, Z-Score and F-Score
NAS:RNAC Key Ratios
Market Cap $ M | 398.27 |
Enterprise Value $ M | 325.20 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 4.47 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 26.00 |
EPS (TTM) $ | -49.80 |
Beneish M-Score | 11.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -665.50 |
EV-to-EBIT | -1.37 |
EV-to-EBITDA | -1.38 |
PEG | -- |
Shares Outstanding M | 17.78 |
Net Margin (%) | -844.91 |
Operating Margin % | -332.32 |
Pre-tax Margin (%) | -917.97 |
Quick Ratio | 1.33 |
Current Ratio | 1.33 |
ROA % (ttm) | -125.96 |
ROE % (ttm) | -- |
ROIC % (ttm) | -104.23 |
Dividend Yield % | -- |
Altman Z-Score | -4.90 |
RNAC Number of Guru Trades
RNAC Volume of Guru Trades
Gurus Latest Trades with NAS:RNAC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RNAC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cartesian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RNAC
Total 0- 1